Literature DB >> 20435655

Trends and burden of bronchiectasis-associated hospitalizations in the United States, 1993-2006.

Amy E Seitz1, Kenneth N Olivier, Claudia A Steiner, Ruben Montes de Oca, Steven M Holland, D Rebecca Prevots.   

Abstract

BACKGROUND: Current data on bronchiectasis prevalence, trends, and risk factors are lacking; such data are needed to estimate the burden of disease and for improved medical care and public health resource allocation. The objective of the present study was to estimate the trends and burden of bronchiectasis-associated hospitalizations in the United States.
METHODS: We extracted hospital discharge records containing International Classification of Diseases, 9th Revision, Clinical Modification codes for bronchiectasis (494, 494.0, and 494.1) as any discharge diagnosis from the State Inpatient Databases from the Agency for Healthcare Research and Quality. Discharge records were extracted for 12 states with complete and continuous reporting from 1993 to 2006.
RESULTS: The average annual age-adjusted hospitalization rate from 1993 to 2006 was 16.5 hospitalizations per 100,000 population. From 1993 to 2006, the age-adjusted rate increased significantly, with an average annual percentage increase of 2.4% among men and 3.0% among women. Women and persons aged > 60 years had the highest rate of bronchiectasis-associated hospitalizations. The median cost for inpatient care was 7,827 US dollars (USD) (range, 13-543,914 USD).
CONCLUSIONS: The average annual age-adjusted rate of bronchiectasis-associated hospitalizations increased from 1993 to 2006. This study furthers the understanding of the impact of bronchiectasis and demonstrates the need for further research to identify risk factors and reasons for the increasing burden.

Entities:  

Mesh:

Year:  2010        PMID: 20435655      PMCID: PMC2951757          DOI: 10.1378/chest.10-0099

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  17 in total

1.  An investigation into causative factors in patients with bronchiectasis.

Authors:  M C Pasteur; S M Helliwell; S J Houghton; S C Webb; J E Foweraker; R A Coulden; C D Flower; D Bilton; M T Keogan
Journal:  Am J Respir Crit Care Med       Date:  2000-10       Impact factor: 21.405

Review 2.  Bronchiectasis: sex and gender considerations.

Authors:  Brian M Morrissey; Richart W Harper
Journal:  Clin Chest Med       Date:  2004-06       Impact factor: 2.878

3.  Bronchiectasis in Finland: trends in hospital treatment.

Authors:  O Säynäjäkangas; T Keistinen; T Tuuponen; S L Kivelä
Journal:  Respir Med       Date:  1997-08       Impact factor: 3.415

Review 4.  Bronchiectasis: update of an orphan disease.

Authors:  A F Barker; E J Bardana
Journal:  Am Rev Respir Dis       Date:  1988-04

5.  The distinction between cost and charges.

Authors:  S A Finkler
Journal:  Ann Intern Med       Date:  1982-01       Impact factor: 25.391

6.  Bronchiectasis: a review of 187 cases in children with follow-up pulmonary function studies in 58.

Authors:  E M Glauser; C D Cook; G B Harris
Journal:  Acta Paediatr Scand       Date:  1966

7.  Bronchiectasis: an orphan disease with a poorly-understood prognosis.

Authors:  T Keistinen; O Säynäjäkangas; T Tuuponen; S L Kivelä
Journal:  Eur Respir J       Date:  1997-12       Impact factor: 16.671

8.  Clinical, pathophysiologic, and microbiologic characterization of bronchiectasis in an aging cohort.

Authors:  M B Nicotra; M Rivera; A M Dale; R Shepherd; R Carter
Journal:  Chest       Date:  1995-10       Impact factor: 9.410

Review 9.  Bronchiectasis: not an orphan disease in the East.

Authors:  K W Tsang; G L Tipoe
Journal:  Int J Tuberc Lung Dis       Date:  2004-06       Impact factor: 2.373

10.  Cost of hospitalization for preterm and low birth weight infants in the United States.

Authors:  Rebecca B Russell; Nancy S Green; Claudia A Steiner; Susan Meikle; Jennifer L Howse; Karalee Poschman; Todd Dias; Lisa Potetz; Michael J Davidoff; Karla Damus; Joann R Petrini
Journal:  Pediatrics       Date:  2007-07       Impact factor: 7.124

View more
  68 in total

1.  Trends in bronchiectasis among medicare beneficiaries in the United States, 2000 to 2007.

Authors:  Amy E Seitz; Kenneth N Olivier; Jennifer Adjemian; Steven M Holland; D Rebecca Prevots
Journal:  Chest       Date:  2012-08       Impact factor: 9.410

Review 2.  Surgical management of non-cystic fibrosis bronchiectasis.

Authors:  Miyako Hiramatsu; Yuji Shiraishi
Journal:  J Thorac Dis       Date:  2018-10       Impact factor: 2.895

Review 3.  Interventions for bronchiectasis: an overview of Cochrane systematic reviews.

Authors:  Emma J Welsh; David J Evans; Stephen J Fowler; Sally Spencer
Journal:  Cochrane Database Syst Rev       Date:  2015-07-14

Review 4.  Positive expiratory pressure therapy versus other airway clearance techniques for bronchiectasis.

Authors:  Annemarie L Lee; Angela T Burge; Anne E Holland
Journal:  Cochrane Database Syst Rev       Date:  2017-09-27

5.  Respiratory impairment and COPD hospitalisation in older persons: a competing risk analysis.

Authors:  Carlos A Vaz Fragoso; John Concato; Gail McAvay; Peter H Van Ness; Thomas M Gill
Journal:  Eur Respir J       Date:  2012-01-20       Impact factor: 16.671

6.  Virulence adaptations of Pseudomonas aeruginosa isolated from patients with non-cystic fibrosis bronchiectasis.

Authors:  Taylor E Woo; Jessica Duong; Nicole M Jervis; Harvey R Rabin; Michael D Parkins; Douglas G Storey
Journal:  Microbiology       Date:  2016-12       Impact factor: 2.777

Review 7.  Bronchiectasis in older patients with chronic obstructive pulmonary disease : prevalence, diagnosis and therapeutic management.

Authors:  Deborah Whitters; Robert A Stockley
Journal:  Drugs Aging       Date:  2013-04       Impact factor: 3.923

8.  Could vitamin d have a potential anti-inflammatory and anti-infective role in bronchiectasis?

Authors:  Jim Bartley; Jeff Garrett; Cameron C Grant; Carlos A Camargo
Journal:  Curr Infect Dis Rep       Date:  2013-04       Impact factor: 3.725

9.  Lung microbiota and bacterial abundance in patients with bronchiectasis when clinically stable and during exacerbation.

Authors:  Michael M Tunney; Gisli G Einarsson; Lan Wei; Maire Drain; Erich R Klem; Chris Cardwell; Madeleine Ennis; Richard C Boucher; Matthew C Wolfgang; J Stuart Elborn
Journal:  Am J Respir Crit Care Med       Date:  2013-05-15       Impact factor: 21.405

10.  Predominant pathogen competition and core microbiota divergence in chronic airway infection.

Authors:  Geraint B Rogers; Christopher J van der Gast; David J Serisier
Journal:  ISME J       Date:  2014-07-18       Impact factor: 10.302

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.